St. Louis Reporter

There were six companies in the City of St. Louis, Missouri, that received six FDA inspections in the third quarter of 2023, according to reports from the U.S. Food and Drug Administration (FDA).

This is a 50% decrease from the number of companies inspected in the previous quarter, when 12 companies received 13 inspections.

Most of the companies inspected at the time were involved in the Biologics sector. The Devices and Drugs sectors sectors, along with one other sector, tied for second most common type.

There were five companies in line with FDA regulations that do not need to adjust their management operations or regulatory/administrative actions. One should take voluntary action to correct its management operations.

The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.

The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.

Company Name	Area of Business	Inspection Date	Result
Creative Testing Solutions	Biologics	08/31/2023	No Action Indicated (NAI)
Jost Chemical Company	Drugs	08/25/2023	No Action Indicated (NAI)
Jost Chemical Company	Food and Cosmetics	08/25/2023	No Action Indicated (NAI)
Jost Chemical Company	Veterinary	08/25/2023	No Action Indicated (NAI)
Ravi Vij, M.D.	Biologics	07/17/2023	No Action Indicated (NAI)
TJ's Pizza Company	Food and Cosmetics	08/02/2023	Voluntary Action Indicated (VAI)
Turing Medical Technologies, Inc.	Devices	08/02/2023	No Action Indicated (NAI)
Washington University Human Research Protections Office	Biologics	08/04/2023	No Action Indicated (NAI)
Washington University Human Research Protections Office	Devices	08/04/2023	No Action Indicated (NAI)
Washington University Human Research Protections Office	Drugs	08/04/2023	No Action Indicated (NAI)